Oral [spco]
Pilocarpine [orch, phsu]
Xerostomia [sosy]
objectives [inpr]
Oral [spco]
Pilocarpine [orch, phsu]
treatment [ftcn]
Xerostomia [sosy]
SS [geoa]
Methods [inpr]
Medical [ftcn]
Literature [inpr]
reviewed [inpr]
Oral [spco]
Pilocarpine [orch, phsu]
Xerostomia [sosy]
SS [geoa]
radiotherapy [inpr]
Registered [hlca]
MEDLINE [inpr]
Silver [elii]
Database [inpr]
Identified [qlco]
Excluded [idcn]
Elderly [popg]
Cardiac [bpoc]
Pulmonary Disease [dsyn]
Patients [podg]
Post-radiation [tmco]
Xerostomia [sosy]
Incomplete [qnco]
resection [topp]
Salivary Glands [bpoc]
Likely [qlco]
Benefit [qnco]
Oral [spco]
Pilocarpine [orch, phsu]
Sufficient [qlco]
Residual [qlco]
Glandular [qlco]
function [phsf]
Patients [podg]
Radical [chvs]
Surgery [bmod]
Head and Neck Cancer [neop]
Patients [podg]
SS [geoa]
Inflammatory disorder [dsyn]
Benefit [qnco]
Oral [spco]
Pilocarpine [orch, phsu]
Compared [acty]
Patients [podg]
Post-radiation [tmco]
Xerostomia [sosy]
Optimal [qlco]
Dose [qnco]
Oral [spco]
Pilocarpine [orch, phsu]
Likely [qlco]
side effects [ftcn]
mg% [qnco]
Four times daily [tmco]
Multicenter Study [resa]
SS [geoa]
Patients [podg]
Suggest [idcn]
Oral [spco]
Pilocarpine [orch, phsu]
effective [qlco]
Administration [ocac]
Increased [qnco]
Salivary gland secretion [bdsu]
Measured [qlco]
symptoms [ftcn]
Improved [qlco]
Increased [qnco]
secretion [biof]
Salivary Glands, Minor [bpoc]
Conditioning [menp]
Oral Mucosa [bpoc]
Conclusions [idcn]
Oral [spco]
Pilocarpine [orch, phsu]
Likely [qlco]
Benefit [qnco]
Patients [podg]
SS [geoa]
Reducing [qlco]
symptoms [ftcn]
Xerostomia [sosy]
Salivary gland secretion [bdsu]
Controlled Study [resa]
Needed [qlco]
Patients [podg]
SS [geoa]
Elderly [popg]
Patients [podg]
Cardiovascular disease [dsyn]
treated [topp]
Moderate-Dose [resa]
Oral [spco]
Pilocarpine [orch, phsu]
Copyright [inpr]
Company [mnob, orgt]
